There have been rumours swirling over recent weeks (months) that CannaStrips maker might not make it through due diligence on Canaccord’s big $12m cross-border financing of them.
While CEO Brad Eckenweiler stops short of guaranteeing that order will go through, he told Equity.Guru’s Chris Parry in this livestreaming interview, that his company has filed every document requested, hit every milestone asked for, and expects that process to end in the next week.
While he was at it, he walked us through the CannaStrips facility, which is being built out right now, and discusses the California regulatory landscape. It’s a killer chat. Enjoy.
— Chris Parry
FULL DISCLOSURE: Lifestyle Delivery Systems is an Equity.Guru marketing client